Results 11 to 20 of about 65,141 (315)

Which Pharmacovigilance for Vaccines? [PDF]

open access: greenTherapies, 2007
Vaccines are not separate health products but anti-infectious medicines administered for the large part prophylactically and for which the effect is immunological and not pharmacological. They should be evaluated by the usual methods of clinical pharmacology and pharmacovigilance, taking into account certain specificities (mechanism of action ...
Hervé Le Louët   +11 more
openalex   +5 more sources

Pharmacovigilance inspections [PDF]

open access: greenIndian Journal of Pharmacology, 2008
Patricia Fitzgerald
openalex   +3 more sources

Pharmacovigilance in oncology [PDF]

open access: yesInternational Journal of Clinical Pharmacy, 2018
AbstractBackground Side effects of cancer therapy are one of the most important issues faced by cancer patients during their illness. Pharmacovigilance, namely the science and activities aimed at monitoring the safety of drugs, is particularly important in oncology, due to the intrinsic biologic toxicity of antineoplastic agents, their narrow ...
Paolo Baldo   +4 more
openaire   +3 more sources

Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004–2015

open access: yesBMC Infectious Diseases, 2021
Background Norovirus is an important cause of acute gastroenteritis globally. However, norovirus is rarely laboratory confirmed or recorded explicitly as a cause of hospitalization.
Elsa Negro Calduch   +2 more
doaj   +1 more source

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias [PDF]

open access: yes, 2020
Several pharmacoepidemiology networks have been developed over the past decade that use a distributed approach, implementing the same analysis at multiple data sites, to preserve privacy and minimize data sharing.
Brown, Jeffrey S.   +5 more
core   +2 more sources

Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

open access: yesDrugs in R&D, 2018
Background We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra®) tablets. Methods A survey with a ≤ 6-month observation period after the start of administration was conducted, targeting insomnia patients who were ...
Yuko Asai   +5 more
doaj   +1 more source

Pharmacovigilance of Biosimilars [PDF]

open access: yes, 2013
In lieu of an abstract, here is the article\u27s first paragraph: Biotech industry forms the backbone of the current pharmaceutical products. Seven out of top ten anticipated drugs of the industry in 2014 will be biologics [1].
Chablani, Lipika
core   +2 more sources

Bayesian model selection in logistic regression for the detection of adverse drug reactions [PDF]

open access: yes, 2015
Motivation: Spontaneous adverse event reports have a high potential for detecting adverse drug reactions. However, due to their dimension, exploring such databases requires statistical methods.
Marbac, Matthieu   +2 more
core   +2 more sources

Social media mining for identification and exploration of health-related information from pregnant women [PDF]

open access: yes, 1989
Widespread use of social media has led to the generation of substantial amounts of information about individuals, including health-related information.
Chandrashekar, Pramod Bharadwaj   +3 more
core   +8 more sources

Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources

open access: yesInternational Journal of Population Data Science, 2023
Introduction In randomised controlled trials (RCTs), bleeding outcomes are often assessed using definitions provided by the International Society on Thrombosis and Haemostasis (ISTH).
Alexander Hartenstein   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy